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Introduction: Postoperative peritoneal adhesions (PPAs) is a common complication of abdominal sur-
geries causing significant morbidity and mortality. The inflammatory response to damaged peritoneal
tissue is a speculated culprit. The aim of this study is to investigate the protective effect of pimecrolimus,
an anti-inflammatory and immunomodulator agent, in formation of PPAs in rats.
Methods: Complied with the Animal Research Reporting In Vivo Experiments (ARRIVE) Guidelines
Checklist, 50 Albino rats underwent laparotomy and were allocated into 5 groups. In groups 1 to 3,
topical pimecrolimus (25, 50 and 100% concentration, respectively) was applies on a scratched area of
peritoneum. In group 4, only topical Eucerin was used and group 5, was the control group. On post-
operative days 7 and 28, five rats from each group were randomly selected and the tensile strength and
adhesiveness of intraabdominal fibrotic bundles were assessed.
Results: There was no significant difference in tensile strength and adhesiveness, between the groups on
postoperative day 7. On postoperative day 28, however, the tensile strength was significantly lower in
pimecrolimus groups than in Eucerin (<0.001) and control (<0.001) groups. Groups with higher con-
centrations of pimecrolimus (group 2 and 3) developed significantly less adhesions than group 1, in
which lower pimecrolimus concentration was used.
Conclusion: Administration of topical pimecrolimus decrease adhesions and their tensile strength on
postoperative day 28 in rats.
© 2020 The Authors. Published by Elsevier Ltd on behalf of Surgical Associates Ltd. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Postsurgical peritoneal adhesions (PPAs) can develop in 67e03%
of laparotomies and about 97% of gynecological surgeries [1,2].
These are pathological fibrous bands that can bind to viscera and
abdominal wall. PPAs can cause gastrointestinal obstruction and
infertility in women [3]. The use of anti-inflammatory drugs, anti-
coagulants, fibrinolytics, mechanical devices to separate intestinal. Azadi), davoodabadi28ab@
yahoo.com (H. Akbari),
mnoureddini@kaums.ac.ir
ier Ltd on behalf of Surgical Assoloops and omental patch has been proposed to prevent the devel-
opment of PPAs [4e8]. Laparoscopic approaches have been shown
to reduce the incidence of adhesions [9e11]. Other effective agents
include tissue plasminogen activator (t-PA), gonadotropin releasing
hormone (GnrH), immunomodulators such as transforming growth
factor-beta (TGF-b), interlukin-6 (IL-6), tumor necrosis factor-alpha
(TNF-a), non-steroidal anti-inflammatory drugs (NSAIDs), cortico-
steroids, calcium channel blockers, fibrinolysin and immune sup-
pressors [12e15]. These act either by decreasing fibroblastic
activity or by modulating fibrinolysis pathways. Despite various
measures, PPAs are still a common problem.
Pimecrolimus, an immune suppressive agent with direct action
on T-cells, is available in ointment form and is used topically
without systemic absorption [16,17]. An interesting advantage ofciates Ltd. This is an open access article under the CC BY-NC-ND license (http://
Fig. 1. No adhesion present.
Fig. 2. Adhesion bands, needs fine blunt dissection, 51e100 g required to dissect
bands.
Fig. 3. Adhesion bands, needs coarse blunt dissection.
Fig. 4. Adhesion bands with neovascularization, needs course and sharp dissection.
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modulatory activity with low systemic immunosuppressive po-
tential. The mechanism of action of pimecrolimus is the blockage of
T-cell activation via inhibiting the protein phosphatase calcineurin,
preventing calcineurin from dephosphorylating the nuclear factor
of activated T cells (NF-AT), a transcription factor, which in turn
leads to the blockage of signal transduction pathways in T cells and
inhibition of the synthesis of inflammatory cytokines, specifically
Th1- and Th2-type cytokines. Pimecrolimus has also been shown to
prevent the release of cytokines and pro-inflammatory mediators
from mast cells 16, 17. This study was conducted to evaluate the
effect of topical pimecrolimus on tensile strength and adhesiveness
of postoperative peritoneal adhesions in rats.
2. Methods
After approval of the ethics committee, this study was per-
formed according to the ARRIVE statement [18] in the Animal
Research Center of kashan medical university Fifty male albino rats
weighing 250e300 gwithmean age of 11weeks were enrolled. The
animals were kept in air-conditioned colony rooms and fed with
standard rat chow diet, water and libitum. The animals were
housed at the Center for Laboratory Animal Care and were accli-
matized for oneweek before the experiment. After adaptation, they
were randomly assigned to five different groups of equal numbers.
The only exclusion criterion was the death of the rat during the
study. All of the animals were fasted for 12 h before surgery.
2.1. Procedure
General anesthesia was induced by 60 mg/kg intramuscular
injection of ketamine and 4 mg/kg xylazine. We did not administer
any antibiotics. After hair removal, the abdomen was cleaned with
1% antiseptic povidone-iodine solution and a 4 cm midline lapa-
rotomy incision was made in the supine position. On the right side
and anterior to the cecum, with approximately 1 cm distance from
the midline incision, a 2 2 centimeter area of the peritoneumwas
scratched by 20 knocks of dry sterile surgical gauze to induce
serosal petechiae (Fig. 8). The terminal ileum and cecum also were
scraped with the same technique. Hemorrhage was induced in all
cases and finally, the two intra-abdominal traumatized surfaces
were brought in contact. In three groups (1, 2 and 3) 2 mL of 25, 50
and 100% topical pimecrolimus was applied immediately after
scraping on the surfaces. In group 4, 2 mL of eucerin cream was
applied and for group 5, the control group, no intervention was
used.
At the end of the procedure, the cecum was repositioned in the
abdominal cavity, the midline incision was closed with absorbable
5/0 polyglactin (Vicryl) continuous sutures for the fascia and non-
absorbable 5/0 nylon interrupted sutures for skin closure. All rats
were observed closely for development of surgical complications.
On the 7th and 28th postoperative day, 5 rats were randomly
selected from each group. Repeated laparotomy was performed
with a 3 cm incision, parallel but far from the first mid line incision,
the anterior abdominal wall was reopened, the fascia was elevated
gently and adhesive bands were evaluated using the method
described by Linsky et al. [19]. The severity of adhesions was
determined grossly by trying to separate the adhesions using the
following classification:
Grade 1: no adhesions are seen (Fig. 1)
Grade 2: release needs fine blunt dissection (Fig. 2)
Grade 3: release needs blunt dissection (Fig. 3)
Grade 4: adhesion bands with neovascularization, requiring
sharp dissection (Fig. 4)
Fig. 6. Grade 3: 101e150 g required to dissect bands from viscera to abdominal wall.
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with a tensiometer and classified as follows:
Grade 0: no tension required (Fig. 1)
Grade 1: 0e50 g required to dissect the adhesion bands
attaching viscera to abdominal wall (Fig. 5)
Grade 2: 51e100 g required to dissect the adhesion bands
attaching viscera to abdominal wall (Fig. 2)
Grade 3: 101e150 g required to dissect the adhesion bands
attaching viscera to abdominal wall (Fig. 6)
Grade 4: 151e200 g required to dissect the adhesion bands
attaching viscera to abdominal wall (Fig. 7)
Adhesion grade and tensile strength were evaluated and
recorded separately by two blinded observers.
Data analysis: was performed using IBM SPSS Statistics 16. The
means and standard deviations were calculated and data normality
exam was performed. For comparing the data, ANOVA and Tukey
post hoc test were used. A p-value of less than 0.05 was considered
as significant.Fig. 7. Grade 4: 151e200 g required to dissect bands from viscera to abdominal wall.3. Results
All animals tolerated the procedure well. No signs of infection
were observed in the incision site throughout the study period.
Three rats died due to unknown cause, on day 2, 6 and 23 and were
excluded from the study. Adhesiveness and tensile strength were
significantly less in groups 1, 2 and 3 on the 28th day in comparison
to the eucerin and control group. No difference was seen on the 7th
day. Comparing the different concentrations of pimecrolimus,
lower adhesion scores and less tensile strength was observed with
higher concentrations on day 28 (Table 1, Digram 1 and 2). The
Kolmogorov-Smirnov test (KeS test) showed normal distribution of
tensile strength and adhesiveness for all 5 groups.Fig. 8. Scraped by 20 knocks of dry gauze to create serous petechia and hemorrhage.4. Discussion
There are many experimental models for engendering peritoneal
adhesions such as damaged uterine horn model, peritoneal damage
model and bacterial peritonitis model [19,20,21]. We choose the
scraping model for this study, because direct mechanical intestinal
wall damage from gauze scrapingmimics abdominal surgery damage.
Many efforts have been made to prevent post-surgical peritoneal
adhesions, but an effective protocol has not yet been developed.
However, there are some recommendations; careful tissue handling,
minimizing surgical trauma, using laparoscopic surgical techniques,
avoiding excessive desiccation and ischemia, minimizing the use of
electro cautery, elimination of foreign bodies (starch and talc) and
optimization of hemostasis [22,23]. As mentioned previously, some
preventive agents are under investigation, including anti-
inflammatory drugs, which decrease peritoneal fibrosis via prevent-
ing fibroblast production. Other examples are non-steroidal anti-Fig. 5. Grade 1: 0e50 g required to dissect bands from viscera to abdominal wall.inflammatory drugs (NSAID), corticosteroids, fibrinolytics, and im-
mune suppressors. Anti-inflammatory and immune modulatory
agents have been shown to reduce the extent of PPAs in animal
models [24]. Pimecrolimus is also an immune suppressive agent with
direct action on T-cells and has significant anti-inflammatory activity
and immune modulatory capabilities with low systemic immuno-
suppressive potential [16,17]. We observed a significant decrease in
adhesion formation in rat via applying topical pimecrolimus, espe-
cially with higher concentrations of 50% and 100%. Similar studies
showed decreased adhesion formation with intraperitoneal applying
of colchicine, antibiotics, nitric oxide, extract of green tea, Allium
Sativum (garlic) oil and methylprednisolone [25e31]. Also, intra-
abdominal administration of noxythiolin was effective in decreasing
the intensity of adhesions in rats. Noxythiolin, reduced both the total
and the mean number of adhesions and their mean length of
attachment. The anti-adhesive effect of noxythiolin may be due to its
anticoagulant, cytotoxic or antibacterial properties [32e36].
To our knowledge, there is no similar study evaluating the effect
of pimecrolimus on peritoneal adhesion formation. This topical
cream is an FDA-approved second line treatment for atopic
dermatitis and has no systemic toxicity. The effect of pimecrolimus
is probable not only due to its function as a mechanical barrier, but
also for the anti-inflammatory effect that decreases adhesion for-
mation, as less adhesions were observed in comparison to eucerin
and also with higher concentrations of pimecrolimus.
Table 1
Tensile strength and adhesiveness on the 7th and 28th postoperative day.
time Variable Group 1 Group 2 Group 3 Eucerin Control p-value
7th day Tensile strength (grade) 1.8 ± 0.4 1.7 ± 0.5 2 ± 0.7 1.8 ± 0.4 2.2 ± 0.5 0.64
Adhesiveness (grade) 1.8 ± 0.8 1.7 ± 0.5 1.6 ± 0.5 1.8 ± 0.8 2.0 ± 0.8 0.95
28th day Tensile strength 2.4 ± 0.5 1.2 ± 0.8 1.0 ± 0.8 2.8 ± 0.8 3.6 ± 0.5 <0.001
Adhesiveness 1.4 ± 0.5 1.2 ± 0.8 0.7 ± 0.5 2.0 ± 0.7 2.8 ± 0.4 <0.001
Diagram 1. Adhesiveness on 7th and 28th day.
Diagram 2. Tensile strength on 7th and 28th day.
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Applying topical pimecrolimus decreases postoperative peri-
toneal adhesions in albino rats. As this topical cream has no sys-
temic adverse effects, it might evolve as an effective agent in
decreasing postoperative adhesions. Further investigations is
needed to confirm the efficacy and the optimal dosing of
pimecrolimus.
5.1. Limitations
This study was carried out on a small number of rats and the
follow-up period was short. Future research should be done over a
longer period and with larger sample size.Ethical approval
Approval by the kashan University of Medical Sciences (kaums)
Ethics Committee and supported by Animal Research Laboratory.
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